# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-24-244123
Filing Date
2024-10-25
Accepted
2024-10-25 16:06:08
Documents
24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B4 | d762905d424b4.htm | 424B4 | 2668943
2 | GRAPHIC | g762905g00b98.jpg | GRAPHIC | 120835
3 | GRAPHIC | g762905g00w02.jpg | GRAPHIC | 33938
4 | GRAPHIC | g762905g01n96.jpg | GRAPHIC | 214005
5 | GRAPHIC | g762905g02n01.jpg | GRAPHIC | 239912
6 | GRAPHIC | g762905g02n07.jpg | GRAPHIC | 92348
7 | GRAPHIC | g762905g05g90.jpg | GRAPHIC | 120416
8 | GRAPHIC | g762905g10t06.jpg | GRAPHIC | 219692
9 | GRAPHIC | g762905g14g14.jpg | GRAPHIC | 59005
10 | GRAPHIC | g762905g15a01.jpg | GRAPHIC | 138950
11 | GRAPHIC | g762905g19m19.jpg | GRAPHIC | 135979
12 | GRAPHIC | g762905g30c65.jpg | GRAPHIC | 194615
13 | GRAPHIC | g762905g35e11.jpg | GRAPHIC | 116475
14 | GRAPHIC | g762905g38i22.jpg | GRAPHIC | 157664
15 | GRAPHIC | g762905g43d06.jpg | GRAPHIC | 115662
16 | GRAPHIC | g762905g46d29.jpg | GRAPHIC | 378313
17 | GRAPHIC | g762905g59y26.jpg | GRAPHIC | 159440
18 | GRAPHIC | g762905g69v12.jpg | GRAPHIC | 97203
19 | GRAPHIC | g762905g72w39.jpg | GRAPHIC | 208362
20 | GRAPHIC | g762905g73h34.jpg | GRAPHIC | 200843
21 | GRAPHIC | g762905g76a01.jpg | GRAPHIC | 56899
22 | GRAPHIC | g762905g78p09.jpg | GRAPHIC | 163648
23 | GRAPHIC | g762905g98o86.jpg | GRAPHIC | 133280
24 | GRAPHIC | g762905g99m62.jpg | GRAPHIC | 129622
| Complete submission text file | 0001193125-24-244123.txt |  | 7413330

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-282469 | Film No.: 241397111
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)